 |
|
|
|
© All-Russian National Academy of Mycology,
2001
© A. Sergeev, 1999-2001
|
|
|
|
| |
Second
SCIO trial: results |
|
|
| |
When
the 4 groups of patients were compared, the highest ratio of
clinical cure was in two groups of pulsed therapy (90,9% or
20/22), counted both for itraconazole and fluconazole. The continuous
therapy resulted with clinical cure of 86,3% (19/22), the difference
was statistically insignificant.
On this chart first 3 bars are shown for itraconazole,
second for fluconazole, third for terbnafine, fourth for ketoconazole.
Bars represent
number of patients.
The highest numbers of the cured cases were recorded in the
group of pulsed therapy with itraconazole (14). The difference
was also insignificant when comparing group 1 (3 cycles of pulsed
itraconazole) and group 3 (3 months of continuous therapy with
terbinafine). |
| |
Had someone
else conducted such trials? |
| |
|
|
|
